OncoTAb
PrivateLast Round
Grant
Oct 5, 2016
Total Funding Raised
$2.79M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoTAb operates in Healthcare & Life Sciences and is based in Charlotte, North Carolina. Its latest recorded funding round was a Grant round in October 2016.
OncoTAb is a diagnostic equipment company that develops a blood test kit designed for early-stage breast cancer detection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Imaging, Drug Discovery
Business Model
B2B2C
Customer Profile
Government Contracts, Hardware Sales, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoTAb Comparables
Compare OncoTAb with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mammogen | 89% | |
| Syantra Inc. | 81% | |
| Astrin Biosciences | 79% |
For institutional investors. Book with your work email.
OncoTAb Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OncoTAb Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| State of North Carolina | Grant |
| Inception Micro Angel Fund | Debt, Angel |
| North Carolina Biotechnology Center | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 60% MoM.
- Jun 18, 2026
Monthly visitors grew 179% MoM, from 184 to 514.
For institutional investors. Book with your work email.
OncoTAb Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoTAb's valuation, stock price, and market status.
Is OncoTAb a public or private company?
OncoTAb is a private company.
What is the current stock price of OncoTAb?
OncoTAb is a private company, so its shares have no public market price. Caplight tracks OncoTAb's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoTAb worth (valuation)?
Valuation information for OncoTAb is not publicly available.
Can I buy OncoTAb stock?
OncoTAb shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoTAb's last funding round?
OncoTAb's most recent funding round was Grant on October 5, 2016.
Who are the main investors in OncoTAb?
Key investors in OncoTAb include National Cancer Institute, State of North Carolina, Inception Micro Angel Fund, North Carolina Biotechnology Center.
Will OncoTAb IPO soon?
No public IPO plans have been announced for OncoTAb.
How can I track OncoTAb secondary market activity?
Caplight tracks bids, offers, and trades in OncoTAb's shares on secondary markets.